| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/10/1993 | CA2121904A1 Dimeticon pastilles |
| 06/10/1993 | CA2101162A1 Dna encoding a human 5-ht1e receptor and uses thereof |
| 06/10/1993 | CA2057289A1 Pharmaceutical preparation for inhibiting the replication of various viruses |
| 06/09/1993 | EP0545913A1 Delivery systems for pharmacological agents |
| 06/09/1993 | EP0545212A1 Use of glucocorticoid monoesters, especially dexamethasone-in-sulfobenzoate, for the preparation of a parenterally applicable medicament for the treatment of diseases for which glucocorticoids are indicated |
| 06/09/1993 | EP0545194A1 Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof |
| 06/09/1993 | EP0545016A1 Composition for nucleic acid complex transfer in suspension eukaryotic cells |
| 06/09/1993 | EP0544900A1 Transdermal nicotine absorption dosage unit and process |
| 06/09/1993 | EP0544878A1 Asialoglycoprotein-conjugated medicinal agent |
| 06/09/1993 | EP0544815A1 Peptides from the GMP-140 lectinbindingdomain and selectin binding ligands on carbonhydrates |
| 06/09/1993 | EP0544671A1 COLONIC-TARGETED ORAL DRUG-DOSAGE FORMS BASED ON CROSSLINKED HYDROGELS CONTAINING AZOBONDS AND EXHIBITING pH-DEPENDENT SWELLING |
| 06/09/1993 | EP0417075B1 Minoxidil gel |
| 06/09/1993 | EP0368920B1 Lectines fixing beta-d-galactoside |
| 06/09/1993 | DE4140194A1 Ein dihydropyridinderivat in nanosolform enthaltendes arzneimittel und seine herstellung A dihydropyridine derivative containing in nanosol drug and its manufacture |
| 06/09/1993 | DE4140191A1 Retardform fuer ein 3-indolylessigsaeurederivat enthaltendes arzneimittel und seine herstellung Release form for a 3-indolylacetic acid derivative containing drug and its manufacture |
| 06/09/1993 | DE4140184A1 Akutform fuer ein flurbiprofen enthaltendes arzneimittel und seine herstellung Acute form for a drug-containing flurbiprofen and its manufacture |
| 06/09/1993 | DE4140116A1 Dimeticon-pastillen Dimethicone pastilles |
| 06/09/1993 | DE4140003A1 DNA encoding low mol.wt. glutaminase - used for glutamine isolation from human tissues or fluids for treating cancer and HIV |
| 06/09/1993 | CN1072863A Enhandced skin penetration system for improved topical delivery of drugs |
| 06/09/1993 | CN1072843A Gel-type cosmetic composite |
| 06/08/1993 | US5218113 N-substituted thiolactams |
| 06/08/1993 | US5218105 3'-Phosphoramidating a 5'-aldehydic-protected nucleoside; forming a 5'-Schiff Base by reaction with a polyamine and reducing; reacting with a phosphorothioated oligonucleotide |
| 06/08/1993 | US5218096 Sweet, stable, nontoxic polysaccharide from treatment of mixture of lactose and starch or derivative with transferase enzyme |
| 06/08/1993 | US5218039 Pan emulsion |
| 06/08/1993 | US5217998 Conjugate of deferoxamine covalently joined to a polysaccharide for use in binding ferric or aluminum ions in body fluids |
| 06/08/1993 | US5217965 Stabilized solid dosage forms of choline metal carboxymethylcellulose salicylate compositions |
| 06/08/1993 | US5217954 Chelate agent added for oxidation resistance, aggregation resistance |
| 06/08/1993 | US5217870 Monoclonal antibodies against CDX |
| 06/08/1993 | US5217866 Polynucleotide assay reagent and method |
| 06/08/1993 | US5217720 Coated solid medicament form having releasability in large intestine |
| 06/08/1993 | US5217719 Surface-treated sodium bicarbonate particle and molded preparation thereof |
| 06/08/1993 | US5217713 Anticancer agents |
| 06/08/1993 | US5217710 Containing tin compound |
| 06/08/1993 | US5217492 Biomolecule attachment to hydrophobic surfaces |
| 06/05/1993 | CA2084432A1 Contrast agents for ultrasound imaging |
| 06/02/1993 | EP0544450A1 Supported Microspheres |
| 06/02/1993 | EP0544292A2 Method of introduction of nucleic acids in cells |
| 06/02/1993 | EP0544000A1 N-acetylcarboxymethylchitosan derivative and production thereof |
| 06/02/1993 | EP0543943A1 Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories. |
| 06/02/1993 | CN1072602A Enhanced skin penetration system for improved topical delivery of drugs |
| 06/02/1993 | CN1072593A Emulsions containing alkyl-or alkylglycerophosphoryl choline surfactants and methods of use |
| 06/01/1993 | US5216130 Coupling polysaccharide spacer arm to central albumin core of complex; radioactive labels |
| 06/01/1993 | US5216115 Polyarylate containing derivatives of the natural amino acid L-tyrosine |
| 06/01/1993 | US5216011 Solvent mixture consisting of propylene glycol and water |
| 06/01/1993 | US5215889 Catalytic and reactive polypeptides and methods for their preparation and use |
| 06/01/1993 | US5215758 Controlled release matrix suppository for pharmaceuticals |
| 06/01/1993 | US5215757 Encapsulated materials |
| 06/01/1993 | US5215743 Tumor necrosis factor formulations |
| 06/01/1993 | US5215739 Spray gel base and spray gel preparation using thereof |
| 06/01/1993 | CA1318621C Heteropolysaccharide s-657 |
| 06/01/1993 | CA1318602C Controlled release combination of carbidopa/levodopa |
| 06/01/1993 | CA1318600C Sustained release etodolac |
| 06/01/1993 | CA1318599C Pharmaceutical compositions containing dyclonine hc1 and phenol |
| 06/01/1993 | CA1318598C Transdermal formulation containing 3-isobutyryl-2-isopropylpyrazolo [1,5-a] pyridine |
| 06/01/1993 | CA1318543C Sorbitol coated comestible and method of preparation |
| 05/29/1993 | CA2067519A1 Use of glucocorticoid compounds for the production of compositions for the treatment of disorders in which glucocorticoids are indicated |
| 05/28/1993 | WO1993010795A1 Topical emollient for prevention and treatment of circulatory induced lesions |
| 05/28/1993 | WO1993010765A1 Controlled release oxycodone compositions |
| 05/28/1993 | CA2101169A1 Topical emollient for prevention and treatment of circulatory induced lesions |
| 05/28/1993 | CA2083232A1 Fibronectin-containing ophthalmic solution, method of manufacture of an ophthalmic solution, method of preserving an ophthalmic solution, and methods of treatment of ophthalmic wounds |
| 05/27/1993 | WO1993010440A1 Gel particle contrast media for improved diagnostic imaging |
| 05/27/1993 | WO1993010215A1 Purified proteoglycan betaglycan, compositions, and methods |
| 05/27/1993 | WO1993010163A2 Adhesive hydrogels having extended use lives and process for the preparation of same |
| 05/27/1993 | WO1993010151A1 Receptor for oncostatin m and leukemia inhibitory factor |
| 05/27/1993 | WO1993010134A1 Ganglioside analogs |
| 05/27/1993 | WO1993010131A1 Benzoate esters of alkoxylated methyl glucosides |
| 05/27/1993 | WO1993009893A1 Developed blank layout angle bracket |
| 05/27/1993 | WO1993009813A1 Therapeutic compounds |
| 05/27/1993 | WO1993009812A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES |
| 05/27/1993 | WO1993009810A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
| 05/27/1993 | WO1993009805A1 Polar lipid composition of plant origin |
| 05/27/1993 | WO1993009794A1 Suppression of megakaryocytopoiesis by neutrophil activating peptide-2 |
| 05/27/1993 | WO1993009790A1 Methods of inhibiting restenosis |
| 05/27/1993 | WO1993009788A1 Triplex forming oligonucleotide reagents targeted to the neu oncogene promoter and method of use |
| 05/27/1993 | WO1993009787A1 Emulsions containing alkyl- or alkylgylcerophosphoryl choline surfactants and methods of use |
| 05/27/1993 | WO1993009785A1 Risedronate delayed-release compositions |
| 05/27/1993 | WO1993009781A1 Sustained-release trapidil tablet |
| 05/27/1993 | WO1993009775A1 Unbuffered premixed ranitidine formulation |
| 05/27/1993 | WO1993009762A2 Method for extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
| 05/27/1993 | WO1993006812A3 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
| 05/27/1993 | WO1993000100A3 Wound cleanser |
| 05/27/1993 | CA2378820A1 Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 05/27/1993 | CA2124857A1 Methods of inhibiting restenosis |
| 05/27/1993 | CA2123585A1 Polar lipidic composition from plants |
| 05/27/1993 | CA2123508A1 Developed blank layout angle bracket |
| 05/27/1993 | CA2123487A1 Adhesive hydrogels having extended use lives and process for the preparation of same |
| 05/27/1993 | CA2123486A1 Method for extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents |
| 05/27/1993 | CA2123228A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
| 05/27/1993 | CA2123213A1 Ganglioside analogs |
| 05/27/1993 | CA2121681A1 Gel particle contrast media for improved diagnostic imaging |
| 05/27/1993 | CA2121502A1 Emulsions containing alkyl-or alkylglycerophosphoryl choline surfactants and methods of use |
| 05/27/1993 | CA2100466A1 Unbuffered premixed ranitidine formulation |
| 05/26/1993 | EP0543572A1 Method for entrapment of active materials in chitosan |
| 05/26/1993 | EP0543521A2 High dosage topical forms of collagenase |
| 05/26/1993 | EP0543454A2 Encapsulated particles useful as contrast agents in ultrasound and X-ray imaging compositions and methods |
| 05/26/1993 | EP0542977A1 Oral composition based on an antibiotic material and clay |
| 05/26/1993 | EP0542914A1 Improved diagnostic and therapeutic compositions |
| 05/26/1993 | EP0542855A1 Microcapsules having a combined atelocollagen/polyholoside wall coagulated by a divalent cation. |
| 05/26/1993 | EP0542770A1 Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
| 05/26/1993 | EP0542756A1 Method of introducing a peptide into the cytosol |